The collagen-platelet interaction

Current Opinion in Hematology

Volumn 5, Issue 5, 1998, Pages 314-320

  Barnes, Michael J ^a   Knight, C Graham ^a   Farndale, Richard W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; FC RECEPTOR; INTEGRIN; PHOSPHOLIPASE C; THROMBOCYTE RECEPTOR; VON WILLEBRAND FACTOR;

HEMOSTASIS; MOLECULAR INTERACTION; PRIORITY JOURNAL; REVIEW; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOSIS;

EID: 0031714707     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199809000-00002     Document Type: Review

References (54)

1. Sixma JJ, van Zanten GH, Huizinga EG, van der Plas RM, Verkleij M, Wu • Y-P, Gros P, de Groot PG: Platelet adhesion to collagen: an update. Thromb Haemost 1997, 78:434-438. A good, concise review.
2. Moroi M, Jung SM: Platelet receptors for collagen. Thromb Haemost • 1997, 78:439-444. A good, compact review complementing that of Sixma et al. (Thromb Haemost 1997, 78:434-438).
3. Rand JH, Glanville RW, Wu X-X, Ross JM, Zangari M, Gordon RE, Schwartz E, Potter BJ: The significance of subendothelial von Willebrand factor. Thromb Haemost 1997, 78:445-450.
4. Moroi M, Jung SM, Nomura S, Sekiguchi S, Ordinas A, Diaz-Ricart M. • Analysis of the involvement of the von Willebrand factor-glycoprotein Ib interaction in platelet adhesion to a collagen-coated surface under flow conditions. Blood 1997, 90:4413-4424. An interesting conceptual study on platelet interaction with vWf.
5. Bienkowska J, Cruz M, Atiemo A, Handin R, Liddington R. The von •• Willebrand factor A3 domain does not contain a metal ion-dependent adhesion site motif. J Biol Chem 1997, 272:25162-25167. An important structural study, along with that of Huizinga et al. (Structure 1997, 5:1147-1156), on the vWf A3 domain.
6. Huizinga EG, van der Plas RM, Kroon J, Sixma JJ, Gros P: Crystal structure •• of the A3 domain of human von Willebrand factor: implications for collagen binding. Structure 1997, 5:1147-1156. Details important structural features of the A3 domain of vWf, complementing the findings of Bienkowska et al. (J Biol Chem 1997, 272:25162-25167).
7. Hoylaerts MF, Yamamoto H, Nuyts K, Vreys I, Deckmyn H, Vermylen J. von • Willebrand factor binds to native collagen VI primarily via its A1 domain. Biochem J 1997, 324:185-191. The authors present evidence that, in contrast to collagens I and III, collagen VI binds to the A1 domain of vWf.
8. Moroi M, Jung SM, Shinmyozu K, Tomiyama Y, Ordinas A, Diaz-Ricart M. Analysis of platelet adhesion to collagen-coated surface under flow conditions: the involvement of glycoprotein VI in the platelet adhesion. Blood 1996, 88:2081-2092.
9. 1-recognition sites in collagen type 1. Biochem J 1994, 299:791-797.
10. 1-independent platelet reactivity. Biochem J 1995 306:337-344.
11. Nakamura T, Jamieson GA, Okuma M, Kambayashi J-I, Tandon NN. Platelet • adhesion to native type I collagen fibrils: role of GP VI in divalent cation-dependent and -independent adhesion and thromboxane A2 generation. J Biol Chem 1998, 273:4338-4344. Indicates the involvement of glycoprotein VI in cation-independent platelet adhesion to collagen fibers and confirms the importance of glycoprotein VI for collagen-induced platelet activation.
12. 2+ bound to a highly-conserved metal ion-binding site in the I domain.
13. 1-recognition sequence in collagen III that is important to the platelet reactivity of the collagen.
14. Glattauer V, Werkmeister JA, Kirkpatrick A, Ramshaw JAM. Identification of the epitope for a monoclonal antibody that blocks platelet aggregation induced by type III collagen. Biochem J 1997, 323:45-49.
15. 2α2(IV). EMBO J 1993, 12:4795-4802.
16. 1.
17. 1 (GPIa/IIa) I-domain inhibits platelet collagen interaction. Thromb Haemost 1997, 77:981-985.
18. 1.
19. 1 activity on human platelets. Blood 1993, 82:2693-2703.
20. 2 gene coding sequence. Blood 1997, 89:1939-1943.
21. 1. 22. Huang T-F, Liu C-Z, Yang S-H. Aggretin, a novel platelet aggregation inducer from snake (Calloselasma rhodostoma) venom, activates phospholipase C by acting as a glycoprotein Ia/IIa agonist. Biochem J 1995, 309:1021-1027.
22. syk activation in human platelets stimulated with collagen is dependent upon glycoprotein Ia/IIa and actin polymerization. Thromb Haemost 1996, 75:648-654.
23. 1 integrin is a necessary co-receptor for collagen-induced activation of Syk and the subsequent phosphorylation of phospholipase Cγ2 in platelets. J Biol Chem 1996, 271:26668-26676.
24. Kamiguti AS, Moura-da-Silva A, Laing GD, Knapp T, Zuzel M, Crampton JM, Theakston RDG. Collagen-induced secretion-dependent phase of platelet aggregation is inhibited by the snake venom metalloproteinase jararhagin. Biochim Biophys Acta 1997, 1335:209-217.
25. 1 by a snake venom protein.
26. 1 in glycoprotein VI-mediated signals from convulxin is suggested.
27. Moroi M, Jung SM, Okuma M, Shinmyozu K. A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. J Clin Invest 1989, 84:1440-1445.
28. Ryo R, Yoshida A, Sugano W, Yasanuga M, Nakayama K, Saigo K, Adachi M, Yamaguchi N, Okuma M. Deficiency of P62, a putatative collagen receptor, in platelets from a patient with defective collagen-induced platelet aggregation. Am J Hematol 1992, 39:25-31.
29. 3 as candidate CRP-XL receptors.
30. fak, are attenuated by the lack of glycoprotein VI-derived input from collagen.
31. Barnes MJ, Knight CG, Farndale RW. The use of collagen-based model peptides to investigate platelet-reactive sequences in collagen. Biopolymers 1996, 40:383-397.
32. Gibbins J, Asselin J, Farndale RW, Barnes MJ, Law CL, Watson SP. Tyrosine phosphorytation of the Fc receptor γ-chain in collagen-stimulated platelets. J Biol Chem 1996, 271:18095-18099.
33. Gibbins JM, Okuma M, Farndale RW, Barnes MJ, Watson SP. • Glycoprotein VI is the receptor which underlies tyrosine phosphorylation of the Fc receptor γ-chain. FEBS Lett 1997, 413:255-259. Shows the link between glycoprotein VI and the Fc receptor γ-chain.
34. syk.
35. 1 occupancy.
36. syk in transducing signals from collagen to phospholipase Cγ2.
37. Tsuji M, Ezumi Y, Arai M, Takayama H: A novel association of Fc receptor •• γ-chain with glycoprotein VI and their co-expression as a collagen receptor in human platelets. J Biol Chem 1997, 272:23528-23531. Demonstrates the association between Fc receptor γ-chain and glycoprotein VI, and the absence of Fc receptor γ-chain in glycoprotein VI-deficient platelets.
38. Melford SK, Turner M, Briddon SJ, Tybulewicz VLJ, Watson SP. Syk and Fyn are required by mouse megakaryocytes for the rise in intracellular calcium induced by a collagen-related peptide. J Biol Chem 1997, 272:27539-27542.
39. 2 by 38-kDa mitogen activated protein kinase in collagen-stimulated human platelets, Eur J Biochem 1997, 245:751-759.
40. Kramer RM, Roberts EF, Strifler BA, Johnstone EM. Thrombin induces activation of p38 MAP kinase in human platelets. J Biol Chem 1995, 270:27395-27398.
41. 2) in thrombin-stimulated human platelets. J Biol Chem 1996, 271:27723-27729.
42. 2 in agonist-stimulated human platelets and HeLa cells. J Biol Chem 1998, 273:4449-4458.
43. Saklatvala J, Rawlinson L, Waller RJ, Sarsfield S, Lee JC, Morton LF, Barnes MJ, Farndale RW. Role for p38 mitogen-activated protein kinase in platelet activation caused by collagen or a thromboxane analogue. J Biol Chem 1996, 271:6586-6589.
44. 2 by U73343. Biochem Pharmacol 1997, 53:1257-1262.
45. q-deficient mice. Nature 1997, 389:183-186.
46. 2+ as a means of regulating phosphatidylserine expression. Shows collagen to lie, at least partially, upstream from thrombin in regulating coagulation.
47. Dachary-Prigent J, Pasquet JM, Fressinaud E, Toti F, Freyssinet J-M, Nurden AT. Aminophospholipid exposure, microvesiculation and abnormal protein tyrosine phosphorylation in the platelets of a patient with Scott syndrome: a study using physiologic agonists and local anaesthetics. Br J Haematol 1997, 99:959-967.
48. Guan J-L. Focal adhesion kinase in integrin signaling. Matrix Biol 1997, 16:195-200.
49. fak; underscores the idea that a direct link between integrins and the enzyme may be unnecessary.
50. Raja S, Avraham S, Avraham H. Tyrosine phosphorylation of the novel protein-tyrosine kinase RAFTK during an early phase of platelet activation by an integrin glycoprotein IIb-IIIa-independent mechanism. J Biol Chem 1997, 272:10941-10947.
51. Barnes MJ, Knight CG, Farndale RW. Collagens and atherosclerosis: cell-collagen interaction. In Atherosclerosis XI. Edited by Jacotot B, Mathe D, Fruchart J-C. Amsterdam: Elsevier; 1998:299-306.
52. Chiang TM, Rinaldy A, Kang AH. Cloning, characterization, and functional • studies of a nonintegrin platelet receptor for type I collagen. J Clin Invest 1997, 100:514-521. An interesting paper characterizing a collagen type-specific receptor, whose role in collagen-induced platelet activation has yet to be defined.
53. Chiang TM, Kang AH. A synthetic peptide derived from the sequence of a type I collagen receptor inhibits type I collagen-mediated platelet aggregation. J Clin Invest 1997, 100:2079-2084.
54. Verkleij MW, Morton LF, Knight CG, de Groot PG, Barnes MJ, Sixma JJ. Simple collagen-like peptides support platelet adhesion under static but not under flow conditions: interaction via α2β1 and vWf with specific sequences in native collagen is a requirement to resist shear forces. Blood 1998, 91:3808-3816.